Lopid and Macrodantin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lopid (gemfibrozil) and Macrodantin (nitrofurantoin, macrocrystalline). Common drug interactions include weight increased among females.

The phase IV clinical study analyzes what interactions people have when they take Lopid and Macrodantin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

What is Macrodantin?

Macrodantin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 3,755 Macrodantin users. Check the latest studies of Macrodantin.



On Jul, 10, 2026

17 people who take Lopid and Macrodantin together, and have interactions are studied.

Lopid and Macrodantin drug interactions.

What are the common drug interactions of Lopid and Macrodantin, by gender? *:

female:

  1. Weight increased
  2. Neuropathy peripheral (surface nerve damage)
  3. Asthenia (weakness)
  4. Back pain
  5. Cardiac disorder
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chest pain
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Drooling (drop saliva uncontrollably from the mouth)
  10. Drug hypersensitivity

male:

n/a

What are the common drug interactions of Lopid and Macrodantin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Neuropathy peripheral (surface nerve damage)
  2. Type 2 diabetes mellitus
  3. Weight increased

40-49:

  1. Eustachian tube dysfunction (eustachian tube problems like clearing the ears when flying, suffering infection, and recurring ear infection)
  2. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  3. Eyelid ptosis (falling of the upper or lower eyelid)
  4. Fatigue (feeling of tiredness)
  5. Fibromyalgia (a long-term condition which causes pain all over the body)
  6. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
  9. Frustration (a form of poorly expressed anger)
  10. Gastric mucosal hypertrophy (inflammation and ulcers (breaks on the skin or on the surface of an organ) of the mucosa (inner lining) of the stomach)

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Drooling (drop saliva uncontrollably from the mouth)
  3. Psychotic disorder
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Disturbance in attention
  6. Vision blurred

60+:

  1. Fall
  2. Abdominal pain
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Skin ulcer
  8. Weight increased
  9. Accident
  10. Angina pectoris (chest pain due to ischemia of the heart muscle)

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 8 people, 47.06%
  2. Scoliosis (a medical condition in which a person's spine is curved from side to side): 2 people, 11.76%
  3. Pain: 2 people, 11.76%
  4. Chest Pain: 2 people, 11.76%
  5. Back Pain: 2 people, 11.76%
  6. Pulmonary Congestion (congestion in the lungs): 1 person, 5.88%
  7. Impaired Gastric Emptying: 1 person, 5.88%
  8. Cough: 1 person, 5.88%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lopid and Macrodantin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lopid and Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrodantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil and nitrofurantoin, macrocrystalline (the active ingredients of Lopid and Macrodantin, respectively), and Lopid and Macrodantin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: